Tag Archives: Merck KGaA

Merck CEO Outlines Next Two Years as IFPMA President, Raises Ire on IP

Merck KGaA CEO Stefan Oschmann spoke last week in New York as he accepted the two-year role as president of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the R&D industry’s global trade group based in Geneva.
Posted in Global, leadership, Strategy | Also tagged , , , , , , | Leave a comment

Merck KGaA Acquires Sigma-Aldrich for $17 Billion

Merck KGaA has announced that it has agreed to buy Sigma-Aldrich for $140 per share in cash, or a total of $17 billion. The purchase will expand the reach of Merck’s EMD Millipore chemical and equipment division, “increasing the company’s presence in North America and adding exposure to fast-growing Asian markets,” according to a press release from […]
Posted in Deals | Also tagged , , | Leave a comment

Merck KGaA Announces Restructuring

Merck KGaA announced measures intended to reduce costs and increase efficiency to ensure the long-term success of its business model. The measures are part of a comprehensive transformation program that will be implemented in two phases. In the first two years, Merck plans to implement a new leadership organization, implement efficiency measures, and develop a […]
Posted in Strategy | Also tagged | 1 Comment

Merck KGaA MS Drug on the Fast Track

Merck KGaA received word July 25 that its application for the multiple sclerosis treatment Cladribine had received priority review status by FDA, decreasing the evaluation period from 10 months to six months, and closing the gap between Merck and the competition. “This is a critical milestone on the path to potential approval for short-course therapy […]
Posted in Strategy | Also tagged , , , , , , , | Leave a comment
  • Categories

  • Meta